• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊维菌素对实验性旋毛虫病的作用。

Effect of ivermectin on experimental trichinosis.

作者信息

el-Azzouni M Z

机构信息

Department of Parasitology, Faculty of Medicine, Alexandria University, Egypt.

出版信息

J Egypt Soc Parasitol. 1997 Aug;27(2):331-40.

PMID:9257971
Abstract

Ivermectin is a potent macrolytic lactone causing paralysis in many nematodes and arthropods through an influx of chloride ions across cell membranes. This work was carried out to assess its effect against T. spiralis infection in Swiss albino mice as a single dose treatment. Ivermectin was administered to infected mice: one day before, the same day, 5, 10 and 35 days post Trichinella infection. Assessment of the drug effect was through: a) Parasitological study which included: adult count, Larval count, measurements of the length of the adult females, larvae and the reproductive capacity index; b) Scanning electron microscopic study of the adult & larva. Scanning EM changes were described, the results showed that it was most effective when administered on the same day of infection, its effect diminished progressively thereafter.

摘要

伊维菌素是一种强效的大环内酯类药物,通过氯离子跨细胞膜内流,使许多线虫和节肢动物麻痹。本研究旨在评估其作为单剂量治疗对瑞士白化小鼠旋毛虫感染的效果。将伊维菌素给予感染小鼠:在旋毛虫感染前一天、感染当天、感染后5天、10天和35天。通过以下方式评估药物效果:a)寄生虫学研究,包括:成虫计数、幼虫计数、成年雌性、幼虫长度测量以及生殖能力指数;b)成虫和幼虫的扫描电子显微镜研究。描述了扫描电镜变化,结果表明在感染当天给药时最有效,此后其效果逐渐减弱。

相似文献

1
Effect of ivermectin on experimental trichinosis.伊维菌素对实验性旋毛虫病的作用。
J Egypt Soc Parasitol. 1997 Aug;27(2):331-40.
2
The effect of flubendazole on the course of Trichinella spiralis infection in mice: parasitological study.氟苯达唑对小鼠旋毛虫感染进程的影响:寄生虫学研究
J Egypt Soc Parasitol. 1995 Aug;25(2):453-9.
3
Cyclosporin A in experimental trichinosis; parasitological study.
J Egypt Soc Parasitol. 1991 Dec;21(3):621-31.
4
Studies on T. spiralis and T pseudospiralis larvae recovered from mice immunized with heterologous Trichinella antigen.对从小鼠体内回收的旋毛虫和伪旋毛虫幼虫的研究,这些小鼠用异源旋毛虫抗原进行了免疫。
J Egypt Soc Parasitol. 1993 Apr;23(1):161-70.
5
Reduction in the number of infective Trichinella spiralis larvae in mice by use of homeopathic drugs.使用顺势疗法药物减少小鼠体内感染性旋毛虫幼虫的数量。
Forsch Komplementarmed Klass Naturheilkd. 2005 Aug;12(4):202-5. doi: 10.1159/000086306. Epub 2005 Aug 29.
6
Immunization against trichinellosis using microwaved larvae of Trichinela spiralis.使用旋毛虫微波处理幼虫进行旋毛虫病免疫接种。
J Egypt Soc Parasitol. 2007 Apr;37(1):121-33.
7
Cyclosporin A in experimental trichinosis scanning electron microscopic study.
J Egypt Soc Parasitol. 1992 Dec;22(3):767-73.
8
Therapeutic efficacy of Dormectin, Ivermectin and Levamisole against different stages of Trichinella spiralis in rats.多拉菌素、伊维菌素和左旋咪唑对大鼠旋毛虫不同阶段的治疗效果。
Turkiye Parazitol Derg. 2011;35(2):86-91. doi: 10.5152/tpd.2011.22.
9
Therapeutic potential of myrrh and ivermectin against experimental Trichinella spiralis infection in mice.没药和伊维菌素对小鼠实验性旋毛虫感染的治疗潜力。
Korean J Parasitol. 2013 Jun;51(3):297-304. doi: 10.3347/kjp.2013.51.3.297. Epub 2013 Jun 30.
10
Mice immunzation using crude Trichinella spiralis antigen.使用旋毛虫粗抗原对小鼠进行免疫。
J Egypt Soc Parasitol. 2002 Aug;32(2):391-403.

引用本文的文献

1
Niosomal versus nano-crystalline ivermectin against different stages of Trichinella spiralis infection in mice.尼莫司汀脂质体与纳米结晶伊维菌素对感染期不同阶段旋毛虫的疗效比较。
Parasitol Res. 2021 Jul;120(7):2641-2658. doi: 10.1007/s00436-021-07172-1. Epub 2021 May 4.
2
Therapeutic potential of myrrh and ivermectin against experimental Trichinella spiralis infection in mice.没药和伊维菌素对小鼠实验性旋毛虫感染的治疗潜力。
Korean J Parasitol. 2013 Jun;51(3):297-304. doi: 10.3347/kjp.2013.51.3.297. Epub 2013 Jun 30.
3
Epidemiology, diagnosis, treatment, and control of trichinellosis.
旋毛虫病的流行病学、诊断、治疗与防控
Clin Microbiol Rev. 2009 Jan;22(1):127-45, Table of Contents. doi: 10.1128/CMR.00026-08.